Vis enkel innførsel

dc.contributor.authorMuller, Ashley Elizabeth
dc.contributor.authorClausen, Thomas
dc.contributor.authorSjøgren, Per
dc.contributor.authorOdsbu, Ingvild
dc.contributor.authorSkurtveit, Svetlana
dc.date.accessioned2022-07-26T06:28:53Z
dc.date.available2022-07-26T06:28:53Z
dc.date.created2018-12-18T13:23:00Z
dc.date.issued2019
dc.identifier.citationScandinavian Journal of Pain. 2019, 19 (2), .
dc.identifier.issn1877-8860
dc.identifier.urihttps://hdl.handle.net/11250/3008431
dc.description.abstractIntroduction: While the Nordic countries have considerably stricter controls on opioid prescribing for chronic non-cancer pain than other countries, previous research has warned that prescription of strong opioids is increasing. Objectives: This study examines consumption of and developments in dispensed prescribed opioids to individuals receiving ambulatory care from 2006-2017, using publicly available data from each of three Nordic countries’ national prescription registries. Methods: Repeated, cross-sectional design. One-year prevalence of all dispensed prescribed opioids in ATC N02A group were reported for Norway, Denmark, and Sweden in the period 2006-2017 by gender. One-year prevalence of the weak opioids tramadol and codeine and the strong opioid oxycodone were then reported separately over this period for each country. The mean defined daily dose (DDD) per user per year, an estimate of the amount of opioids prescribed, was reported for each of the three opioids in 2016. Results: Patterns of dispensed prescribed opioids differ greatly between 2006 and 2017 and between countries, with tramadol increasing in Norway, codeine declining across the board, and oxycodone increasing in all three countries. Norway exceeded Sweden and Denmark in prevalence of all dispensed prescribed opioids, with 12.1% of the female Norwegian population and 9.2% of the male Norwegian population dispensed at least one prescribed opioid as an outpatient in 2016. Norway’s high overall prevalence rates are tempered by dispensing the lowest mean doses of both weak opioids compared to Sweden. Similarly, Sweden dispenses the lowest mean doses of oxycodone but to the largest proportion of its population (3.0%). Conclusion: Significant shifts have occurred in the dispensing of prescribed opioids in Norway, Sweden, and Denmark over the past twelve years. The increasing prevalence of oxycodone in all three countries should continue to be monitored. Prescription registries provide a wealth of publicly available data that can be used to monitor and to guide prescribing policies in a more knowledge-based direction.
dc.description.abstractPrescribed opioid analgesic use developments in three Nordic countries, 2006-2017
dc.language.isoeng
dc.subjectpostoperativ smertebehandling
dc.subjectpostoperative pain management
dc.subjectOpioider
dc.subjectOpioids
dc.subjectKronisk smerte
dc.subjectSmertestillende medikamenter
dc.subjectAnalgetica
dc.titlePrescribed opioid analgesic use developments in three Nordic countries, 2006-2017
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.description.versionacceptedVersion
dc.subject.nsiVDP::Allmennmedisin: 751
dc.subject.nsiVDP::General practice: 751
dc.source.pagenumber9
dc.source.volume19
dc.source.journalScandinavian Journal of Pain
dc.source.issue2
dc.identifier.doi10.1515/sjpain-2018-0307
dc.identifier.cristin1644902
cristin.unitcode7502,3,12,0
cristin.unitnameAvdeling for psykiske lidelser
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.fulltextpostprint
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel